Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaFabian Frontzek, Georg Lenz, Ramona Wullenkord et al.|Nature Communications|2021Cited by 49
Accuracy and prognostic impact of <scp>FDG PET</scp>/<scp>CT</scp> and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A <scp>Nation‐Wide</scp> cohort studyIsabel Ródenas‐Quiñonero, Francisco José Ortuño, Tzu Hua Chen‐Liang et al.|Cancer Medicine|2022Cited by 8
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potentialMiriam Verdú-Bou, José‐Tomás Navarro, Maria João Baptista et al.|Blood Advances|2025Cited by 5
THE ROLE OF FDG‐PET/CT AND BONE MARROW BIOPSY IN DETECTING BONE MARROW INVOLVEMENT IN THE INITIAL STAGING OF FOLLICULAR LYMPHOMA: AN ANALYSIS OF ACCURACY AND PROGNOSTIC IMPACTL. Reguilón Gallego, Francisco José Ortuño, Taoyun Liang et al.|Hematological Oncology|2021Cited by 0
Validation of New International Prognostic Scores, Including Baseline Peripheral Blood Variables, in Patients with Diffuse Large B-Cell Lymphoma and HIV Infection Treated with R-CHOP and Combined Antiretroviral Therapy. Retrospective Study from Spanish Lymphoma Group GeltamoMaría Luisa López Huguet, José‐Tomás Navarro, Mireia Morgades et al.|Blood|2021Cited by 0